358 related articles for article (PubMed ID: 10929044)
1. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population.
Zheng YZ; Tong J; Do XP; Pu XQ; Zhou BT
Br J Haematol; 2000 Jun; 109(4):870-4. PubMed ID: 10929044
[TBL] [Abstract][Full Text] [Related]
2. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
[TBL] [Abstract][Full Text] [Related]
3. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
[TBL] [Abstract][Full Text] [Related]
6. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Hanson NQ; Aras O; Yang F; Tsai MY
Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
[TBL] [Abstract][Full Text] [Related]
7. The C677T mutation of the methylenetetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan.
Hsu LA; Ko YL; Wang SM; Chang CJ; Hsu TS; Chiang CW; Lee YS
Hum Hered; 2001; 51(1-2):41-5. PubMed ID: 11096270
[TBL] [Abstract][Full Text] [Related]
8. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.
Lu Y; Zhao Y; Liu G; Wang X; Liu Z; Chen B; Hui R
Thromb Res; 2002 Apr; 106(1):7-12. PubMed ID: 12165282
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the C677T methylenetetra- hydrofolate reductase mutation in Thai patients with deep vein thrombosis.
Angchaisuksiri P; Pingsuthiwong S; Sura T; Aryuchai K; Busabaratana M; Atichartakarn V
Acta Haematol; 2000; 103(4):191-6. PubMed ID: 11014892
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
[TBL] [Abstract][Full Text] [Related]
11. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
13. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
14. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
[TBL] [Abstract][Full Text] [Related]
15. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
[TBL] [Abstract][Full Text] [Related]
16. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
[TBL] [Abstract][Full Text] [Related]
17. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis.
Isotalo PA; Donnelly JG
Mol Diagn; 2000 Mar; 5(1):59-66. PubMed ID: 10837091
[TBL] [Abstract][Full Text] [Related]
20. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
